2.29
2.97%
-0.07
Dopo l'orario di chiusura:
2.31
0.02
+0.87%
Precedente Chiudi:
$2.36
Aprire:
$2.33
Volume 24 ore:
41,216
Relative Volume:
0.25
Capitalizzazione di mercato:
$61.06M
Reddito:
-
Utile/perdita netta:
$-14.47M
Rapporto P/E:
-1.8468
EPS:
-1.24
Flusso di cassa netto:
$-12.19M
1 W Prestazione:
-2.97%
1M Prestazione:
+8.53%
6M Prestazione:
+4.09%
1 anno Prestazione:
+26.52%
Heartbeam Inc Stock (BEAT) Company Profile
Nome
Heartbeam Inc
Settore
Industria
Telefono
408-899-4443
Indirizzo
2118 WALSH AVE., SUITE 210, SANTA CLARA
Confronta BEAT con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
2.29 | 61.06M | 0 | -14.47M | -12.19M | -1.24 |
VEEV
Veeva Systems Inc
|
234.33 | 38.04B | 2.66B | 665.91M | 1.08B | 4.05 |
DOCS
Doximity Inc
|
74.94 | 14.06B | 516.85M | 174.11M | 217.38M | 0.87 |
SOLV
Solventum Corp
|
73.65 | 12.72B | 8.26B | 66.00M | 1.17B | 0.3682 |
TEM
Tempus Ai Inc
|
71.21 | 11.21B | 640.44M | -743.28M | -206.93M | -11.29 |
HQY
Healthequity Inc
|
112.50 | 9.75B | 1.15B | 96.70M | -161.99M | 1.09 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2020-09-11 | Iniziato | Needham | Buy |
2020-09-02 | Iniziato | Robert W. Baird | Neutral |
2020-01-08 | Iniziato | SunTrust | Buy |
2019-08-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
2019-04-26 | Reiterato | Dougherty & Company | Buy |
2018-07-26 | Reiterato | Lake Street | Buy |
2018-04-26 | Reiterato | The Benchmark Company | Buy |
2018-02-23 | Reiterato | Dougherty & Company | Buy |
2017-11-08 | Reiterato | Dougherty & Company | Buy |
2017-10-26 | Iniziato | Raymond James | Outperform |
2017-10-24 | Iniziato | SunTrust | Buy |
2017-08-09 | Reiterato | Dougherty & Company | Buy |
2017-07-19 | Reiterato | The Benchmark Company | Buy |
2017-04-11 | Reiterato | Dougherty & Company | Buy |
2016-12-02 | Iniziato | Dougherty & Company | Buy |
2016-09-13 | Iniziato | Sidoti | Buy |
2016-08-03 | Reiterato | The Benchmark Company | Buy |
2015-07-28 | Reiterato | Dougherty & Company | Buy |
2013-10-24 | Iniziato | The Benchmark Company | Buy |
2013-08-21 | Iniziato | Dougherty & Company | Buy |
Mostra tutto
Heartbeam Inc Borsa (BEAT) Ultime notizie
US Penny Stocks Spotlight: HeartBeam And Two More Standout Picks - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Submits FDA Application for 12-Lead ECG Synthesis Software - The Globe and Mail
HeartBeam submits 510(k) application to FDA for ECG software - Yahoo Finance
HeartBeam seeks FDA nod for ECG synthesis software - MSN
HeartBeam Submits 12-Lead ECG Synthesis Software to FDA - MPO-mag
BEATHeartbeam, Inc. Latest Stock News & Market Updates - StockTitan
HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software - Business Wire
Blaize Appoints Yoshiaki Fujimori and George de Urioste to Board of Directors - Business Wire
JP Morgan Chase & Company (JPM-N) QuotePress Release - The Globe and Mail
HeartBeam (NASDAQ: BEAT) To Present At JP Morgan 2025 Annual Healthcare Conference - Barchart
Heartbeam Inc (BEAT-Q) QuotePress Release - The Globe and Mail
HeartBeam to Showcase FDA-Cleared Revolutionary Heart Monitor at JP Morgan Healthcare Conference - StockTitan
HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference - Business Wire
HeartBeam’s arrhythmia assessment system gains FDA 510(k) clearance - Yahoo! Voices
FDA clearance adds glow to Heartbeam prospects - BioWorld Online
HeartBeam Wins FDA Nod for Home High-Fidelity Heart Monitor - MPO-mag
HeartBeam announces FDA clearance for high-fidelity ECG system - TipRanks
Heartbeam stock soars to 52-week high, hits $3.48 - Investing.com
FDA clears HeartBeam's novel ECG system for arrhythmia - Investing.com India
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology - Business Wire
HeartBeam And 2 Other US Penny Stocks With Promising Potential - Simply Wall St
The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference - The Manila Times
HeartBeam rises on positive data from two studies on its vector-based technology - MSN
HeartBeam ECG technology shows promise in clinical studies By Investing.com - Investing.com Australia
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference - BioSpace
HeartBeam Touts Data from Study of Vector-Based Tech - MPO-mag
HeartBeam ECG technology shows promise in clinical studies - Investing.com India
HeartBeam announces positive data from two studies at AHA - TipRanks
HeartBeam, Inc. (NASDAQ:BEATW) Short Interest Update - Defense World
HeartBeam, Inc. (NASDAQ:BEAT) Q3 2024 Earnings Call Transcript - Insider Monkey
HeartBeam (NASDAQ: BEAT) Advances Toward Commercialization of Cardiac Care Tech with FDA Submissions - Barchart
HeartBeam reports net loss of USD 5M in Q3 2024 - Medical Buyer
HeartBeam, Inc. Advances Cardiac Monitoring Solutions - TipRanks
HeartBeam Q3 Loss Widens to $5M as FDA Review Advances for Cardiac Tech | BEAT Stock News - StockTitan
HeartBeam Reports Third Quarter 2024 Results - Business Wire
Spotlight On US Penny Stocks In October 2024 - Simply Wall St
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time - Business Wire
Tripp Investments Alters Stake in Betmakers - MSN
Severfield PLC Executes Share Buy-Back on LSE - MSN
HeartBeam, Inc. (BEAT): A Bull Case Theory - Insider Monkey
HeartBeam (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care - Barchart
HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards - Business Wire
HeartBeam Appoints Robert Eno as New CEO - TipRanks
Upstart Holdings, Inc. (UPST) Registers a Bigger Fall Than the Market: Important Facts to Note - MSN
Diamondback Energy (FANG) Rises Yet Lags Behind Market: Some Facts Worth Knowing - MSN
Lifesaving Portable, AI Augmented Cardiac Monitoring - openPR
HeartBeam names Robert Eno as new CEO for growth phase - Investing.com
HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization - Business Wire
HeartBeam Appoints Robert Eno as Chief Exec - MPO-mag
Dr. Lance Myers Joins HeartBeam As Chief AI Scientist - MPO-mag
Heartbeam Inc Azioni (BEAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):